About Us Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Ceribell’s mission is to make EEG diagnostics widely available,…
Search Results
Not what you’re looking for? Search again
Leadership Team
Our Leadership Team Led by a visionary executive team, the Ceribell Point-of-Care EEG system is the first critical care EEG and quickly becoming an important vital sign for the brain…
Culture & Careers
Ceribell Culture & Careers Working for Ceribell Transformative The Ceribell team aspires to be a changing force within healthcare, bringing disruptive technologies to market and improving diagnostics and treatment. To…
Newsroom
Newsroom Press Releases 04/02/2024 Ceribell Appoints Sean Manni as Senior Vice President of Sales 01/04/2024 Ceribell to Present at the 42nd Annual J.P. Morgan Healthcare Conference 10/30/2023 Ceribell Launches ClarityPro™…
Contact Us
Contact Us Reach out to us Email us EEG@ceribell.com Call us Technical support: 1.800.763.0183 General inquiries: 1.800.436.0826 For General Inquiries Learn More About Our Products Schedule a Demo…
NCSE and the Impact of Rapid EEG
Josef Parvizi, Mary Kay Bader and Paul Vespa discuss the need and impact of Rapid EEG Josef Parvizi, MD, PhD is a Professor of Neurology and Neurological Sciences at Stanford…
Safe EEG Monitoring During COVID-19 Pandemic
Dr. Parshaw Dorriz discusses Safe EEG Monitoring During COVID-19 Pandemic Parshaw Dorriz received his residency training in neurology at Virginia Commonwealth University, and completed a fellowship in epilepsy at the…
EEG and Imaging Signatures in COVID-19 Patients
Dr. Matthew Markert discusses EEG and imaging signatures in COVID-19 patients. Dr. Matthew Markert is an epileptologist and biostatistician, with expertise in neuroimaging surrogate markers of cortical disease in population…